These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16382337)

  • 41. Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.
    Arcangeli S; Tozzi A; Tantucci M; Spaccatini C; de Iure A; Costa C; Di Filippo M; Picconi B; Giampà C; Fusco FR; Amoroso S; Calabresi P
    J Cereb Blood Flow Metab; 2013 Feb; 33(2):278-86. PubMed ID: 23149555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.
    Bollen E; Puzzo D; Rutten K; Privitera L; De Vry J; Vanmierlo T; Kenis G; Palmeri A; D'Hooge R; Balschun D; Steinbusch HM; Blokland A; Prickaerts J
    Neuropsychopharmacology; 2014 Oct; 39(11):2497-505. PubMed ID: 24813825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment.
    Chepkova AN; Sergeeva OA; Haas HL
    Neurobiol Dis; 2006 Sep; 23(3):512-21. PubMed ID: 16766203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic nicotine-induced switch in Src-family kinase signaling for long-term potentiation induction in hippocampal CA1 pyramidal cells.
    Yamazaki Y; Jia Y; Wong JK; Sumikawa K
    Eur J Neurosci; 2006 Dec; 24(11):3271-84. PubMed ID: 17156388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different mechanisms may be required for maintenance of NMDA receptor-dependent and independent forms of long-term potentiation.
    Grover LM; Teyler TJ
    Synapse; 1995 Feb; 19(2):121-33. PubMed ID: 7725241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of acetylcholinesterase and phosphodiesterase-9A has differential effects on hippocampal early and late LTP.
    Kroker KS; Rast G; Giovannini R; Marti A; Dorner-Ciossek C; Rosenbrock H
    Neuropharmacology; 2012 Apr; 62(5-6):1964-74. PubMed ID: 22245562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-frequency stimulation induces a new form of LTP, metabotropic glutamate (mGlu5) receptor- and PKA-dependent, in the CA1 area of the rat hippocampus.
    Lanté F; de Jésus Ferreira MC; Guiramand J; Récasens M; Vignes M
    Hippocampus; 2006; 16(4):345-60. PubMed ID: 16302229
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo.
    González-Usano A; Cauli O; Agustí A; Felipo V
    J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A form of long-lasting, learning-related synaptic plasticity in the hippocampus induced by heterosynaptic low-frequency pairing.
    Huang YY; Pittenger C; Kandel ER
    Proc Natl Acad Sci U S A; 2004 Jan; 101(3):859-64. PubMed ID: 14711997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term potentiation and the role of N-methyl-D-aspartate receptors.
    Volianskis A; France G; Jensen MS; Bortolotto ZA; Jane DE; Collingridge GL
    Brain Res; 2015 Sep; 1621():5-16. PubMed ID: 25619552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic liver failure in rats impairs glutamatergic synaptic transmission and long-term potentiation in hippocampus and learning ability.
    Monfort P; Erceg S; Piedrafita B; Llansola M; Felipo V
    Eur J Neurosci; 2007 Apr; 25(7):2103-11. PubMed ID: 17439494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
    Rodrigo R; Felipo V
    Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Domoic acid induces a long-lasting enhancement of CA1 field responses and impairs tetanus-induced long-term potentiation in rat hippocampal slices.
    Qiu S; Jebelli AK; Ashe JH; Currás-Collazo MC
    Toxicol Sci; 2009 Sep; 111(1):140-50. PubMed ID: 19564213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient and sustained types of long-term potentiation in the CA1 area of the rat hippocampus.
    Volianskis A; Jensen MS
    J Physiol; 2003 Jul; 550(Pt 2):459-92. PubMed ID: 12794181
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR; Schittl J; Fischmeister R
    Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase.
    Kleppisch T; Pfeifer A; Klatt P; Ruth P; Montkowski A; Fässler R; Hofmann F
    J Neurosci; 1999 Jan; 19(1):48-55. PubMed ID: 9870937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiency.
    Chepkova AN; Sergeeva OA; Görg B; Haas HL; Klöcker N; Häussinger D
    Sci Rep; 2017 Jan; 7():40190. PubMed ID: 28067279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus.
    Zhuo M; Kandel ER; Hawkins RD
    Neuroreport; 1994 May; 5(9):1033-6. PubMed ID: 8080953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.
    Montoliu C; Rodrigo R; Monfort P; Llansola M; Cauli O; Boix J; Elmlili N; Agusti A; Felipo V
    Metab Brain Dis; 2010 Mar; 25(1):39-48. PubMed ID: 20195723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.